Vaccinex (VCNX) Competitor Comparison
We are evaluating the key criteria listed to compare Vaccinex (VCNX) against its competitors in the Biotechnology industry.
Market Capitalization
343 / 368Gross Profits
165 / 278Total Revenue
242 / 300EBITDA
94 / 337Free Cashflow
99 / 352Quick Ratio
353 / 357Earnings per Share
277 / 359Dividend yield
0 / 6Total Cash
355 / 358Performance 3 years
361 / 368Performance 5 years
363 / 368Performance 10 years
353 / 368Linearity 3 years
265 / 368Linearity 5 years
257 / 368Linearity 10 years
271 / 368Total Rank
363 / 368Dividend Rank
296 / 368Valuation Rank
342 / 368Piotroski Rank
346 / 368Muliplier Rank
224 / 368Gross Profits - VCNX ranking 165 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.